CoChat

Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay

Open access

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

ADAM17 and its inhibitor TIMP3 are involved in nephropathy, but their role in diabetic kidney disease (DKD) is unclear. Diabetic Timp3 −/− mice showed increased albuminuria, increased membrane thickness and mesangial expansion. Microarray profiling uncovered a significant reduction of Foxo1 expression in diabetic Timp3 −/− mice compared to WT, along with FoxO1 target genes involved in autophagy, while STAT1, a repressor of FoxO1 transcription, was increased. Re‐expression of Timp3 in Timp3 −/− mesangial cells rescued the expression of Foxo1 and its targets, and decreased STAT1 expression to control levels; abolishing STAT1 expression led to a rescue of FoxO1, evoking a role of STAT1 in linking Timp3 deficiency to FoxO1. Studies on kidney biopsies from patients with diabetic nephropathy confirmed a significant reduction in TIMP3, FoxO1 and FoxO1 target genes involved in autophagy compared to controls, while STAT1 expression was strongly increased. Our study suggests that loss of TIMP3 is a hallmark of DKD in human and mouse models and designates TIMP3 as a new possible therapeutic target for diabetic nephropathy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/emmm.201201475

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Expression of TIMPs and ADAMs in diabetic mice Levels of Timp family proteins expression were analysed by real-time PCR on mRNA extracted from kidneys of diabetic mice and normoglycemic littermates (n = 6, Student's t-test).Real-time PCR analysis of Adam10, 15 and 17 expression in diabetic and healthy kidneys (n = 6).Immunohistochemical staining of kidney sections from healthy and diabetic (STZ-treated) WT mice (picture magnification: 250×).Representative Western blot of kidney proteins extracted from healthy and diabetic WT and Timp3−/− mice showing TIMP3 expression levels. Tubulin was used as loading control. ns, non specific bands. Source data is available for this figure in the Supporting Information.Fluorimetric measurement of ADAM17 proteolytic activity in kidneys of WT and Timp3−/− diabetic, streptozotocin-treated mice compared to untreated control (n = 6, Student's t-test).Soluble form of TNF-α was measured by ELISA on kidney lysates from normoglycemic and diabetic WT and Timp3−/−mice (n = 6, Student's t-test).Western blot assessment of membrane-bound and soluble TNF-α in kidneys from healthy and diabetic WT and Timp3−/− mice. Actin was used as loading control.PAS staining of kidney sections from diabetic and normoglycemic WT and Timp3−/− mice. Arrow indicates arteriolar hyalinosis at the vascular pole, stars indicate tubular dilation and atrophy and open arrowheads indicate interstitial expansion with fibrosis. Picture magnification is shown on the left. Quantification of mean glomerular area and fractional mesangial area is shown. Statistical significance was evaluated by one-way Anova.
Figure 1 Expression of TIMPs and ADAMs in diabetic mice Levels of Timp family proteins expression were analysed by real-time PCR on mRNA extracted from kidneys of diabetic mice and normoglycemic littermates (n = 6, Student's t-test).Real-time PCR analysis of Adam10, 15 and 17 expression in diabetic and healthy kidneys (n = 6).Immunohistochemical staining of kidney sections from healthy and diabetic (STZ-treated) WT mice (picture magnification: 250×).Representative Western blot of kidney proteins extracted from healthy and diabetic WT and Timp3−/− mice showing TIMP3 expression levels. Tubulin was used as loading control. ns, non specific bands. Source data is available for this figure in the Supporting Information.Fluorimetric measurement of ADAM17 proteolytic activity in kidneys of WT and Timp3−/− diabetic, streptozotocin-treated mice compared to untreated control (n = 6, Student's t-test).Soluble form of TNF-α was measured by ELISA on kidney lysates from normoglycemic and diabetic WT and Timp3−/−mice (n = 6, Student's t-test).Western blot assessment of membrane-bound and soluble TNF-α in kidneys from healthy and diabetic WT and Timp3−/− mice. Actin was used as loading control.PAS staining of kidney sections from diabetic and normoglycemic WT and Timp3−/− mice. Arrow indicates arteriolar hyalinosis at the vascular pole, stars indicate tubular dilation and atrophy and open arrowheads indicate interstitial expansion with fibrosis. Picture magnification is shown on the left. Quantification of mean glomerular area and fractional mesangial area is shown. Statistical significance was evaluated by one-way Anova.CC BY · PubMed Central
Figure 2 Analysis of kidneys from WT and Timp3−/− diabetic mice Electron microscopy of kidney sections from WT and Timp3−/− diabetic mice. Quantification of basal membrane thickness is shown on right panel (Student's t-test).Microalbuminuria was determined in WT and Timp3−/− control and diabetic mice as ratio between urinary albumin and creatinine concentration measured by ELISA (n = 3, Student's t-test).Representative western blot analysis of lysates from kidneys of healthy and diabetic WT and Timp3−/− mice. Levels of phosphorylation of Akt (Ser473), ERK (Thr202/Tyr204) and EGFR (Tyr1068) were quantified for STZ-treated animals and expressed as fold increase in the ratio of phospho-protein to total protein (n = 6, Student's t-test). Source data is available for this figure in the Supporting Information.Immunostaining of kidney sections from WT and Timp3−/− diabetic mice. Quantification of each staining is shown on the bottom, picture magnification on the left (n = 6, Student's t-test). CML, N-carboxymethyl-lysine; NitroTyr, nitrotyrosine.
Figure 2 Analysis of kidneys from WT and Timp3−/− diabetic mice Electron microscopy of kidney sections from WT and Timp3−/− diabetic mice. Quantification of basal membrane thickness is shown on right panel (Student's t-test).Microalbuminuria was determined in WT and Timp3−/− control and diabetic mice as ratio between urinary albumin and creatinine concentration measured by ELISA (n = 3, Student's t-test).Representative western blot analysis of lysates from kidneys of healthy and diabetic WT and Timp3−/− mice. Levels of phosphorylation of Akt (Ser473), ERK (Thr202/Tyr204) and EGFR (Tyr1068) were quantified for STZ-treated animals and expressed as fold increase in the ratio of phospho-protein to total protein (n = 6, Student's t-test). Source data is available for this figure in the Supporting Information.Immunostaining of kidney sections from WT and Timp3−/− diabetic mice. Quantification of each staining is shown on the bottom, picture magnification on the left (n = 6, Student's t-test). CML, N-carboxymethyl-lysine; NitroTyr, nitrotyrosine.CC BY · PubMed Central
Figure 3 FoxO1 regulation in healthy and diabetic Timp3−/− kidneys Real-time PCR on kidney mRNA from healthy and diabetic WT and Timp3−/− mice showing FoxO1 and FoxO3A levels of expression (n = 6, Student's t-test).Western blot analysis of cytoplasmic, nuclear and total lysates from kidneys of WT and Timp3−/− diabetic mice. Topoisomerase I (TOPO I) and tubulin were used to normalize levels of nuclear and cytoplasmic proteins, respectively. Densitometric analysis of results are shown on the right (n = 6, Student's t-test). Source data is available for this figure in the Supporting Information.Foxo1 immunostaining on kidney sections from WT and Timp3−/− diabetic mice. Arrows indicate nuclear staining in STZ-WT mice (left panel) or cytoplasmic staining in STZ-Timp3−/− mice (right panel). Magnification: 400×.Higher magnification of panel C (1000×) showing FoxO1 staining in renal tubules (inserts are from Supporting Information Figure S13).Real-time PCR analysis of autophagy related FoxO1 target genes in WT and Timp3−/− diabetic and normoglycemic kidney (n = 6, Student's t-test).
Figure 3 FoxO1 regulation in healthy and diabetic Timp3−/− kidneys Real-time PCR on kidney mRNA from healthy and diabetic WT and Timp3−/− mice showing FoxO1 and FoxO3A levels of expression (n = 6, Student's t-test).Western blot analysis of cytoplasmic, nuclear and total lysates from kidneys of WT and Timp3−/− diabetic mice. Topoisomerase I (TOPO I) and tubulin were used to normalize levels of nuclear and cytoplasmic proteins, respectively. Densitometric analysis of results are shown on the right (n = 6, Student's t-test). Source data is available for this figure in the Supporting Information.Foxo1 immunostaining on kidney sections from WT and Timp3−/− diabetic mice. Arrows indicate nuclear staining in STZ-WT mice (left panel) or cytoplasmic staining in STZ-Timp3−/− mice (right panel). Magnification: 400×.Higher magnification of panel C (1000×) showing FoxO1 staining in renal tubules (inserts are from Supporting Information Figure S13).Real-time PCR analysis of autophagy related FoxO1 target genes in WT and Timp3−/− diabetic and normoglycemic kidney (n = 6, Student's t-test).CC BY · PubMed Central
Figure 4 FoxO1 regulation in T3kd MES13 cell line Analysis of Timp3 mRNA (left panel) and protein (right panel) expression in T3kd or control MES13 cells grown in basal medium (low glucose) or treated with high glucose (25 mM) for 48 h before harvesting. Mannitol treatment was included in the real time PCR experiment as osmolarity control (n = 3, Student's t-test). Source data is available for this figure in the Supporting Information.Real-time PCR on T3kd and control MES13 cells treated as in (A), showing FoxO1 and FoxO3A mRNA modulation (n = 3, Student's t-test).Expression of autophagic FoxO1 target genes in T3kd and control MES13 cells treated with high glucose or mannitol (25 mM), or serum-starved for 24 h before harvesting (n = 3, Student's t-test).Western blot analysis of autophagic FoxO1 target genes on lysates from T3kd and control MES13 cells treated as in (C). Ratio between LC3II and LC3I form is shown on the left (n = 3, Student's t-test).Immunofluorescence (IF) for LC3A/B (red) in T3kd and control MES13 cells treated as in (A). Cells were counterstained with DAPI to detect nuclei (blue). Magnification views: 60×. Scale bars: 20 µm.
Figure 4 FoxO1 regulation in T3kd MES13 cell line Analysis of Timp3 mRNA (left panel) and protein (right panel) expression in T3kd or control MES13 cells grown in basal medium (low glucose) or treated with high glucose (25 mM) for 48 h before harvesting. Mannitol treatment was included in the real time PCR experiment as osmolarity control (n = 3, Student's t-test). Source data is available for this figure in the Supporting Information.Real-time PCR on T3kd and control MES13 cells treated as in (A), showing FoxO1 and FoxO3A mRNA modulation (n = 3, Student's t-test).Expression of autophagic FoxO1 target genes in T3kd and control MES13 cells treated with high glucose or mannitol (25 mM), or serum-starved for 24 h before harvesting (n = 3, Student's t-test).Western blot analysis of autophagic FoxO1 target genes on lysates from T3kd and control MES13 cells treated as in (C). Ratio between LC3II and LC3I form is shown on the left (n = 3, Student's t-test).Immunofluorescence (IF) for LC3A/B (red) in T3kd and control MES13 cells treated as in (A). Cells were counterstained with DAPI to detect nuclei (blue). Magnification views: 60×. Scale bars: 20 µm.CC BY · PubMed Central
Figure 5 FoxO1 subcellular distribution in T3kd MES13 cell line Representative Western blot analysis of total, nuclear and cytoplasmic lysates from T3kd and MES13 control cells grown in low or high glucose. Topoisomerase I and tubulin were used to normalize levels of nuclear and cytoplasmic proteins, respectively. Densitometric analysis of results is shown on the right (n = 3, Student's t-test). Source data is available for this figure in the Supporting Information.Nuclear FoxO1 protein was immunoprecipitated from T3kd and control MES13 cells grown in low or high glucose and then subjected to Western blot with an anti-acetyl-lysine antibody. FoxO1 and Topoisomerase I were used as loading control. Densitometric analysis of results is shown on the right (n = 3, Student's t-test).Chromatin immunoprecipitation (ChIP) on T3kd or control MES13 cells. Primers used to amplify the FoxO1 binding site on LC3a and Atg8 promoters are described in the Materials and Methods section. IgG, negative control; H3 antibody, positive control.
Figure 5 FoxO1 subcellular distribution in T3kd MES13 cell line Representative Western blot analysis of total, nuclear and cytoplasmic lysates from T3kd and MES13 control cells grown in low or high glucose. Topoisomerase I and tubulin were used to normalize levels of nuclear and cytoplasmic proteins, respectively. Densitometric analysis of results is shown on the right (n = 3, Student's t-test). Source data is available for this figure in the Supporting Information.Nuclear FoxO1 protein was immunoprecipitated from T3kd and control MES13 cells grown in low or high glucose and then subjected to Western blot with an anti-acetyl-lysine antibody. FoxO1 and Topoisomerase I were used as loading control. Densitometric analysis of results is shown on the right (n = 3, Student's t-test).Chromatin immunoprecipitation (ChIP) on T3kd or control MES13 cells. Primers used to amplify the FoxO1 binding site on LC3a and Atg8 promoters are described in the Materials and Methods section. IgG, negative control; H3 antibody, positive control.CC BY · PubMed Central
Figure 6 Re-expression of TIMP3 in T3ko primary mesangial cells rescues FoxO1 effect on autophagy genes Rescue of expression of FoxO1 and its targets in T3ko primary cells (pMes) following reintroduction of TIMP3. RNA from T3ko or WT pMes cells infected with GFP or TIMP3 adenovirus and grown either in low or high glucose was used for real-time PCR analysis of FoxO1, Atg5, Atg8, LC3a and Beclin expression (n = 3, Student's t-test).Western blot analysis of T3ko and WT pMes cells infected and treated as in (A). Samples were run on a 4–12% gradient gel (TIMP3, FoxO1, ATG5, ATG8, Beclin and Actin) or on a 15% gel (LC3 and actin). Ratio between LC3II and LC3I form is shown on the left (n = 3, Student's t-test). Source data is available for this figure in the Supporting Information.Immunofluorescence analysis of LC3A/B (red) in T3ko pMes cells infected with AdGFP (left) and AdTimp3 (right) in HG condition. Cells were counterstained with DAPI to detect nuclei (blue). Magnification views: 60×. Scale bars: 20 µm.
Figure 6 Re-expression of TIMP3 in T3ko primary mesangial cells rescues FoxO1 effect on autophagy genes Rescue of expression of FoxO1 and its targets in T3ko primary cells (pMes) following reintroduction of TIMP3. RNA from T3ko or WT pMes cells infected with GFP or TIMP3 adenovirus and grown either in low or high glucose was used for real-time PCR analysis of FoxO1, Atg5, Atg8, LC3a and Beclin expression (n = 3, Student's t-test).Western blot analysis of T3ko and WT pMes cells infected and treated as in (A). Samples were run on a 4–12% gradient gel (TIMP3, FoxO1, ATG5, ATG8, Beclin and Actin) or on a 15% gel (LC3 and actin). Ratio between LC3II and LC3I form is shown on the left (n = 3, Student's t-test). Source data is available for this figure in the Supporting Information.Immunofluorescence analysis of LC3A/B (red) in T3ko pMes cells infected with AdGFP (left) and AdTimp3 (right) in HG condition. Cells were counterstained with DAPI to detect nuclei (blue). Magnification views: 60×. Scale bars: 20 µm.CC BY · PubMed Central
Figure 7 FoxO1 and STAT1 interplay Real-time PCR of STAT1 expression in WT and Timp3−/− diabetic and normoglycemic kidney (n = 6, Student's t-test).Representative western blot analysis of STAT1 expression in kidneys from healthy and diabetic WT and Timp3−/− mice. Quantification for STZ-treated animals is shown on the right (n = 3, Student's t-test). Source data is available for this figure in the Supporting Information.Immunohistochemical staining of diabetic WT and Timp3−/− kidney sections showing STAT1 expression. Magnification: 250×.Real-time PCR of STAT1 expression in T3ko or WT pMes cells infected with GFP or TIMP3 encoding adenovirus (n = 3, Student's t-test).Western blot analysis of STAT1 expression in T3ko or WT pMes cells infected with GFP or TIMP3 encoding adenovirus (representative analysis of three independent experiments with the same results).Western blot analysis on control cells transfected with a pool of control or STAT1 siRNA, confirming inhibition of STAT1 expression.Real-time PCR on T3ko or control pMes cells transfected with a pool of siRNA directed against STAT1, showing reduction of STAT1 expression (n = 3, Student's t-test).Real-time PCR on T3ko or WT pMes cells transfected with a pool of siRNA directed against STAT1, showing reciprocal regulation of STAT1 and FoxO1 expression (n = 3, Student's t-test).
Figure 7 FoxO1 and STAT1 interplay Real-time PCR of STAT1 expression in WT and Timp3−/− diabetic and normoglycemic kidney (n = 6, Student's t-test).Representative western blot analysis of STAT1 expression in kidneys from healthy and diabetic WT and Timp3−/− mice. Quantification for STZ-treated animals is shown on the right (n = 3, Student's t-test). Source data is available for this figure in the Supporting Information.Immunohistochemical staining of diabetic WT and Timp3−/− kidney sections showing STAT1 expression. Magnification: 250×.Real-time PCR of STAT1 expression in T3ko or WT pMes cells infected with GFP or TIMP3 encoding adenovirus (n = 3, Student's t-test).Western blot analysis of STAT1 expression in T3ko or WT pMes cells infected with GFP or TIMP3 encoding adenovirus (representative analysis of three independent experiments with the same results).Western blot analysis on control cells transfected with a pool of control or STAT1 siRNA, confirming inhibition of STAT1 expression.Real-time PCR on T3ko or control pMes cells transfected with a pool of siRNA directed against STAT1, showing reduction of STAT1 expression (n = 3, Student's t-test).Real-time PCR on T3ko or WT pMes cells transfected with a pool of siRNA directed against STAT1, showing reciprocal regulation of STAT1 and FoxO1 expression (n = 3, Student's t-test).CC BY · PubMed Central
Figure 8 TIMP3 and FoxO1 regulation in diabetic patients Real-time PCR on RNA extracted from four controls and five patients affected by Diabetic Nephropathy (Student's t-test).TIMP3 and control staining of kidney sections from healthy and diabetic subjects. Arrows indicate some TIMP3 positive cells. 40× scanning magnification, 10× zoom.Higher magnification of panel (B) (20× zoom).Co-immunofluorescence of control and diabetic human kidney sections showing nuclei (blue) synaptopodin (green) and TIMP3 (red). Merged images are shown on the right panels. Magnification: 63×.Higher magnification of panel (D) (20× zoom). Synaptopodin immunolabelling (green) highlights podocyte foot processes and is characterized by thin linear staining along the surface of the glomerular basement membranes (GBM) of capillary loops. Timp3 immunoreactivity (red) is mainly observed in the podocyte cell body (*) and primary processes (white arrows).
Figure 8 TIMP3 and FoxO1 regulation in diabetic patients Real-time PCR on RNA extracted from four controls and five patients affected by Diabetic Nephropathy (Student's t-test).TIMP3 and control staining of kidney sections from healthy and diabetic subjects. Arrows indicate some TIMP3 positive cells. 40× scanning magnification, 10× zoom.Higher magnification of panel (B) (20× zoom).Co-immunofluorescence of control and diabetic human kidney sections showing nuclei (blue) synaptopodin (green) and TIMP3 (red). Merged images are shown on the right panels. Magnification: 63×.Higher magnification of panel (D) (20× zoom). Synaptopodin immunolabelling (green) highlights podocyte foot processes and is characterized by thin linear staining along the surface of the glomerular basement membranes (GBM) of capillary loops. Timp3 immunoreactivity (red) is mainly observed in the podocyte cell body (*) and primary processes (white arrows).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 98

Metadata

Authors
Fiorentino, L., Cavalera, M., Menini, S., Marchetti, V., Mavilio, M., Fabrizi, M., Conserva, F., Casagrande, V., Menghini, R., Pontrelli, P., Arisi, I., D'Onofrio, M., Lauro, D., Khokha, R., Accili, D., Pugliese, G., Gesualdo, L., Lauro, R., & Federici, M.
Affiliations
  • University of Rome Tor Vergata (IT)
  • Sapienza University of Rome (IT)
  • University of Bari Aldo Moro (IT)
  • European Brain Research Institute (IT)
  • University of Toronto (CA)
  • Columbia University (US)
Corresponding author
Federici, Massimo
Venue
EMBO Molecular Medicine
Published
2013-02-12
Volume
5
Issue
3
Pages
441-455
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W1917997699
Cited by
98
References
53
Citations by year
2026: 2 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 10 · 2020: 6 · 2019: 12 · 2018: 5 · 2017: 5 · 2016: 9 · 2015: 7 · 2014: 10 · 2013: 9
FWCI
8.80
Type
journal article
Language
en
Open access
Licence
Locations
  • EMBO Molecular Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK057539)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
Keywords
TIMP-3, diabetic nephropathy, FOXO1, STAT1, ADAM17, autophagy, albuminuria, mesangial expansion, therapeutic target
MeSH terms
Forkhead Box Protein O1, Albuminuria, Animals, Autophagy, Biopsy, Cell Line, Diabetes Mellitus, Experimental, Diabetic Nephropathies, Gene Expression Regulation, Humans, Kidney Glomerulus, Transfection, Signal Transduction, Mice, Knockout, Tissue Inhibitor of Metalloproteinase-3, Gene Expression Profiling, RNA Interference, Mesangial Cells, STAT1 Transcription Factor, Mice, Forkhead Transcription Factors, Primary Cell Culture

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.